Welcome Message
On the behalf of organizing the committee, we would like to extend an
invitation to join us for the conference on The 6th International
Conference on Drug discovery and drug development ”which is
scheduled to commence on December 07-09,
2023 in Madrid, Spain.
This year's Drug Development Conference is expected to be three days of interactive,
stimulating discussions with 10+ keynote lectures, 50+ plenary lectures, 10+
Young Investigator Forum lectures, and 20+ poster sessions, in addition, there
are no less than 3 workshops and then 2 symposiums.
We also plan to offer a number of technical demonstrations and informal
networking opportunities.
Why Drug Development 2023?
At this three -day event, give presentations, disseminate
information, network with current and potential scientists, make a splash with
new drug breakthroughs, and boost Drug Development reputation. There are
several eminent speakers at this conference who are specialists in
pharmacovigilance. They are disseminating the most recent methods, innovations,
and discoveries in this crucial area.
A platform to promote
your ideology and ensure its value Communicate and communicate with colleagues
and superiors Collaboration, Career development, etc. In addition, it offers the greatest multidisciplinary forum
for pharmacists, medical professionals, researchers, practitioners, and young
achievers to attend the event and discuss workable problems and answers related
to Pharmacists should be aware of the latest advances, trends, and concerns in
the field.
A platform to promote your ideology and ensure
its value Communicate and communicate with colleagues and superiors
Collaboration, Career Development, Personal communication that leads to an
optimistic future Getting out of
Leaving your comfort zone is never simple, presentation of
introspection.
1) A venue where you
can share your ideology and uphold its validity
2) Partnerships,
professional advancement, and interpersonal connection that promote optimism
for the future
3) Breaking out of your comfort zone and giving
speeches about oneself is never simple.
Benefits
of Attending:
Research
scientists, professors, medical professionals, business entrepreneurs, and
research scholars from all over the world will be present at Drug Development 2023 for
discussing their knowledge and views for the betterment of Drug Development and research.
·
Get feedback on early drafts of your
latest work
·
Get to know others in your field
·
Discover the latest research
·
Improve your presentation and communication
skills
·
Visit a new place and have fun
·
Meet your academic heroes
·
Learn beyond your field of interest
For
Business Delegates:
·
Access to all Sessions
·
Handbook & Conference Kit
·
Book Launch event
·
Networking opportunities
·
Certificate of Presentation
·
Group Participation
For
Students and Research Scholars:
·
Poster Competition (Winner will get Best
Poster Award)
·
The network of Young Researchers (YRF
Award for Best Presenter)
·
Student Attendee
Who
to attend?
·
Directors, CEO’s of Organizations
·
Business Development Managers
·
Chief Scientific Officers
·
Professors, Associate Professors,
Assistant Professors
·
Ph.D. Scholars
·
Patent Attorneys
·
Intellectual Property Attorneys
·
Investment Analysts
·
Association, Association presidents and
professionals
·
Drug development and
discovery companies
·
Medical technology companies
·
Universities and institutes
·
Investors and financial services
providers
·
Bio-clusters and incubators
·
Government and public support agencies
About
We warmly welcome you all from all over the world to attend the conference entitled “The 6th International Conference on Drug discovery and drug development scheduled during December 07-09, 2023, which is going to be held in Madrid, Spain.
Drug Development Conference 2023 will serve as a global forum for debating, exchanging, and exploring new fields of research and development as well as for learning about emerging technologies and algorithms in Drug development.
Drug Development Conference 2023 would be a fantastic chance to learn more about pharmacy-related topics and gain practical experience. A group of worldwide leaders in the developing pharmacy practice sectors will be gathered at this International Conference.
The program includes keynote addresses, lectures, interactive workshops, poster presentations, and exhibitions.
Keep in touch with us throughout Drug Development Conference 2023 to help us stay proactive and help Clinical Pharmacy's future take form.
We look forward to your presence in Madrid, Spain.
Best regards,
Drug Development Conference 2023,
Organizing Committee.
Sessions /Tracks
Session 01. Pharmaceutical Sciences
The drug sciences are a
gathering of interdisciplinary spaces of study worried about the plan,
activity, conveyance, and attitude of medications. They apply information from
science (inorganic, physical, biochemical, and insightful), science (life
systems, physiology, natural chemistry, cell science, and sub-atomic science),
the study of disease transmission, measurements, chemometrics, math, physical
science, and synthetic designing.
The drug sciences are
additionally partitioned into a few explicit fortes, with four primary
branches:
• Pharmacology: The investigation of the biochemical and
physiological impacts of medications on individuals.
• Pharmacodynamics: The investigation of the cell and sub-atomic
connections of medications with their receptors. Just "How the medication
deals with the body"
• Pharmacokinetics: The investigation of the components that
control the grouping of medication at different destinations in the body.
Essentially "How the body deals with the medication"
• Pharmaceutical toxicology:
The investigation of the destructive or poisonous impacts of medications.
• Pharmacogenomics: The investigation of the legacy of trademark
examples of communication among medications and organic entities.
• Pharmaceutical
science: The investigation of
medication configuration to enhance pharmacokinetics and pharmacodynamics, and
amalgamation of new medication atoms (Medicinal Chemistry).
• Pharmaceutics: The examination and plan of medication
detailing for ideal conveyance, soundness, pharmacokinetics, and patient
acknowledgment.
• Pharmacognosy: The investigation of prescriptions got from
normal sources
Session 2: Drug
discovery
This research topic aims to publish data on recent advances
in early Drug Discovery
against emerging/neglected tropical diseases, including parasitic, bacterial,
viral, and fungal infections Here, we gather insightful data on the creation of
fresh experimental methods, the discovery of fresh therapeutic plans, and the
mode of action of traditional or cutting-edge antibacterial substances.
Over the past 40 years, the complexity of drug development
has multiplied, necessitating the preclinical stage of drug research, an
investigational new drug (IND) application, and extensive clinical testing
before FDA marketing clearance. Successful Drug Discovery is like finding a safe and
effective oasis in a chemical and biological desert. Because deserts are huge
and oases are tiny, analyses based on the drug development strategy reveal that
the discoverability of viable candidates is extremely sensitive to the accuracy
of predictions. Especially since Drug Discovery is very
difficult to measure late in the process before the project succeeds or fails.
Discovery Development
Preclinical research
Drug development process
Market monitoring
Session 3: Drug Development
Once a lead molecule
has been found through the process of drug discovery, the
process of drug development is used to bring a new pharmaceutical medicine to
market. Preclinical research on microbes and animals is part of this process,
as is requesting regulatory status, such as through the US Food and Drug
Administration, to begin human clinical trials for an investigational new
drug. It may also include the step of securing regulatory approval with a new
drug application to market the drug. It normally takes more than ten years for
a vaccine or medication to be approved, from concept to preclinical testing in
the lab to clinical trial development, including Phase I-III trials.
Session 4: FDA Drug
Review
The structural
similarities between the FDA's drug reviews and many other regulatory bodies'
judgments include high uncertainty, low reversibility, avoiding observable
error, and high political stakes that encourage lobbying by interested parties.
This essay investigates the policy implications of considering FDA drug evaluation as
a politically motivated information processing activity. I contend that the
incentives regulators face place restrictions on how quickly medication reviews
may be completed, that these motivations may make privatization efforts
difficult, and that political pressures may be helpful in identifying
high-priority pharmaceuticals.
·
Pharmaceuticals
·
Disease
·
Politics
·
HIV\ AIDS
·
Prescription Drug Costs
Session 5: Drug Discovery and Screening
The Drug Discovery Process
involves many different stages and series of actions. Typically, it can be
divided into four main stages: Early Drug Discovery, Pre-Clinical Phase,
Clinical Phases, and Regulatory Approval. Let's explore the major steps that
are taken in each of these stages to develop a new drug.
Drug discovery is a
process where a new drug or medication is discovered and aims to identify a
compound therapeutically useful in curing and treating disease. It includes a
wide range of scientific divisions, including biology, chemistry, and
pharmacology. This process associates with the identification of candidates,
synthesis, characterization, validation, optimization, screening, and assays
for therapeutic efficacy.
Drug screening is a process where potential drugs are
identified and optimized before the selection of a candidate drug to progress
to clinical trials. It can involve screening large volumes of chemicals for a
particular biological activity in high-throughput screening assays. Drug
screening mainly includes In-vivo and In-vivo models drug screening.
·
Discovery and Development.
·
Preclinical Researches
·
Clinical Researches
·
FDA Review.
·
FDA
Post-Market Safety Monitoring.
Session 6 : Clinical
trial in Drug Discovery
Today, people are
living longer because of the success of cancer treatments resulting from
previous clinical trials.
Through clinical trials and drug discovery, doctors determine whether new
treatments are safe, effective, and better than current treatments.
Participating in clinical
trials broadens our knowledge about cancer and helps improve cancer care
for future patients. In this way, clinical trials play a major role in the drug
development and Drug Design process.
Helps improve treatment. Clinical trials are key
to advancing the fight against cancer. In today's global scientific age,
clinical trials and drug Discovery are essential to bringing newer and better
medicines to market. Clinical
trials test potential treatments on human volunteers (subjects) to
determine whether they should be approved for wider use in the general
population. For the future of better healthcare, Clinical Trials are
important.
Prevention
trials
Treatment
trials
case-control
studies
Cross-sectional
studies
Session 7: FDA Post-Market Drug Safety Monitoring
Despite the fact that
data from clinical trials is crucial for understanding a drug's efficacy and safety,
it is difficult to know everything there is to know about a drug's safety at
the time of approval. There are restrictions despite the meticulous processes
in the drug development process.
As a result, throughout the weeks, months, and
sometimes even years that make up a product's existence on the market, the true
image of that product's safety actually changes. When FDA receives reports of
concerns with prescription and OTC medications, it may decide to add warnings
to the dosage or usage instructions or take other action in the case of more
serious problems.
In this session You
Will find information on:
·
Supplemental Application
·
INDs for Market Drugs
·
Manufacturer Inspections
·
Generic Drugs
·
Reporting Problems
Session 8: History Of Drug Discovery
Drug discovery and
development has a long history and dates back to the early days of human Civilization. The
first synthetic drug, chloral hydrate, was discovered in 1869 and introduced as
a sedative-hypnotic; it is still available today in some countries. Ancient people in what
is now Switzerland ate poppy seeds (the source of opium) in 2500 BCE. Coca
leaves (the source of cocaine) have been chewed for thousands of years. Folk
medicines made from plants and herbs have also been used since ancient times.
People in ancient Palestine drank wine in 350 BCE.
·
Chinese Medicine
·
Indian Medicine
·
Greek Medicine
·
Roman
Medicine
Session 9: Advanced
Drug Delivery System
An advanced drug delivery
system is also termed a Novel drug delivery system
which improves drug potency, controls drug release to give a sustained
therapeutic effect, and provides greater safety then finally it targets a drug
specifically to the desired tissue. Drug Delivery systems are developed to
deliver a required amount of drugs effectively to appropriate target sites and
to maintain the desired drug levels
Innovative Drug
Delivery Technologies
Implantable Drug
Delivery System
Pediatric Drug Delivery
systems
Routes of Drug
Administration
Session 10: Future trends impacting the pharmaceutical
industry
Gene and cell therapies
could make strong advancements in 2021 providing a new approach to treating
diseases. Cancer treatments have been advancing at an accelerated pace,
offering clinical benefits and increased specificity through engineered cell or
gene therapies. The
Indian pharma industry
is expected to grow to $130 billion by 2030 and become the leading provider of
medicines to the world, said Indian Pharmaceutical Alliance (IPA) Secretary
General, Sudarshan Jain on Thursday.
Top
Pharma Trends in 2022
·
Artificial Intelligence
·
Big Data & Analytics
·
Flexible Production.
·
Precision Medicine
·
Additive Manufacturing
·
Blockchain
·
Extended Reality (XR)
Session 11: Targeted
Drug Delivery
Targeted Drug Delivery,
at times called keen medication delivery, is a strategy for conveying a prescription to a patient in a way that expands the grouping of the drug in
certain pieces of the body compared with others. This method for conveyance
is to a great extent established on nanomedicine, which intends to utilize
nanoparticle-intervened drug conveyance to battle the destructions of ordinary
medication conveyance.
These nanoparticles would be stacked with
medications and focused on explicit pieces of the body where there is exclusively
sick tissue, in this manner staying away from collaboration with solid tissue.
The objective of a focus on drug conveyance framework is to drag out,
confine, target, and have secured drug cooperation with the ailing tissue.
The traditional medication
conveyance framework is the ingestion of the medication across a natural layer,
though the focus on the discharge framework delivers the medication in a dosing
structure. The benefits of the focused-on-discharge framework are a decrease
in the recurrence of the measurements taken by the patient, a more
uniform impact of the medication, a decrease in medication results, and
diminished variance in flowing medication levels. The impediment of the
framework is a significant expense, which makes efficiency more troublesome and
the diminished capacity to change the measurements.
Session 12: Pharmaceutical
Packaging
Pharmaceutical Packaging
is the bundles and the bundling measures for drug arrangements. It includes the
entirety of the activities from creation through drug appropriation channels to
the end shopper. Drug bundling is exceptionally directed yet with some variety
in the subtleties, contingent upon the nation of beginning or the locale.
A few normal variables can include:
confirmation of patient wellbeing, affirmation of the viability of the
medication through the expected time span of usability, consistency of the
medication through various creation parts, careful documentation, all things
considered, and measures, control of the conceivable movement of bundling segments
into the medication, control of corruption of the medication by oxygen,
dampness, heat, and so forth, avoidance of microbial defilement, sterility, and
so on Bundling is frequently associated with apportioning, dosing, and
utilization of the drug item. Correspondence of legitimate use and preventative
marks are additionally managed. Bundling is a basic piece of drug items.
Session 13. Pharmacovigilance And Drug Safety :
Pharmacovigilance is
also called drug safety, it is a pharmacological science that is related to
the detection, collection, assessment, monitoring, and prevention of adverse
effects with therapeutic products. The term "Pharmacovigilance" originated from Pharmakon (Greek for drug) and Vigilare (Latin for to stay
watch).
It usually focuses on adverse drug reactions,
or ADRs, that are defined as any response to a drug that is toxic and
undesirable, including lack of efficacy. Therapeutic errors like high doses,
misuse, and abuse of a drug as well as drug exposure during pregnancy and
breastfeeding, are significant.
Drug Safety
Advanced Methods in
Pharmacovigilance
Artificial Intelligence
in Pharmacovigilance
Ecopharmacovigilance
Substance-Based Medical
Devices.
Session 14.Pharmaceutical Industry:
The pharmaceutics 2023 industry
discovers, develops, produces, and markets drugs or pharmaceutical drugs for
use as medications to be administered to patients. , with the aim to cure them,
vaccinate them, or alleviating symptoms. Pharmaceutics 2023
companies may deal in generic or brand medications and medical devices.
They are subject to a
variety of laws and regulations that govern the patenting, testing, safety,
efficacy using drug testing, and marketing of drugs. The global pharmaceutics
2023 market produced treatments worth $1,228.45 billion in 2020 and showed a
compound annual growth rate (CAGR) of 1.8%.
Orphan Drugs
Drug Development and
Manufacturing
Drug Marketing
Industrial Safety and
Efficacy.
Session 15 :
Pharmacogenomics(Genomic Approaches to Drug Discovery)
The branch of genetics is concerned with how a person's genetic characteristics influence their likelihood
of responding to therapeutic medications. Pharmacogenomics is likely to lead to improved drug management for heart disease, cancer, asthma,
depression, and a variety of other diseases soon. It also intends to eliminate
the trial-and-error approach to prescription by pushing clinicians to learn
about their patient's genes, how they work, and how this may affect the efficacy
of their current or future medicines.
Drug therapy
Challenges of pharmacogenomics
Pharmacogenomics in clinical therapeutics
Cancer pharmacogenomics
Pharmacokinetic aspects
Clinical efficacy and
safety evaluation
Session 16: Current
Market and Technology
The high prevalence
rate of health diseases, the implementation of drug discovery, and
bioinformatics technology are the factors driving the drug discovery industry.
The technologies and
drug types are widely used for a variety of reasons. High Throughput Screening
(HTS) approaches enable the pharmaceutical industry
to screen vast libraries of drugs. Combinatorial chemistry is the process of
creating many structurally different molecules. Nanotechnology-based drug
discovery resolutions are beginning to produce significant new perspectives of
how biological systems work.
Global drug delivery
market
New technologies
Metabolomics
Biochips
Nanotechnology
Session 17:
Translational Medicine
Our patients and their diseases are the driving force behind translational medicine.
Translational research
spans the spectrum from molecular and cell biology through preclinical models
to patient investigations and back again, guided by this fundamental goal.
Encourages and promotes laboratory and clinical researchers to collaborate
across disciplines. Incorporates public wishes, with communities being involved
in determining their requirements for health innovation. Identifies and
promotes the use of the most effective medical and health practices.
Human diseases
Dissemination research
Diffusion research
New treatment and
approaches to medical care
Session 18:
Pharmaceutical Industry
The pharmaceutical industry is the discovery, development, and manufacture of drugs and medications
(pharmaceuticals) by public and private organizations. The pharmaceuticals industry
consists of drug manufacturers, biotechnology companies,
and the distribution and wholesale companies that handle the products produced.
Companies making related products, such as vitamins, other health supplements,
or diagnostic substances, are also included.
Research and development
Global sales and
marketing
Challenges that face the
pharmaceutical industry
Pharma companies
Session 19:
Transdermal drug delivery system
Transdermal therapy
systems are defined as self-contained, self-contained dosage forms that, when
applied to undamaged skin, release the drug to the systemic circulation at a
controlled rate. A simple patch that adheres to your skin like an adhesive
bandage and uses passive medication diffusion across the skin as the delivery
mechanism.
Skin-MediatedTherapies
and Vaccines
Risk-BasedStrategies
Cosmeceuticals
Latest advances in TDDS
Session 20: Toxicology
Toxicology is the scientific
study of the harmful effects of substances on living beings. It entails
observing and reporting symptoms that emerge because of toxic material
exposure. Toxicology
studies are used in the drug development process to assess the safety of possible
medication candidates. This is done with the help of relevant animal models and
tried-and-true methodologies. The goal is to translate the animal responses
into an understanding of the risk for human subjects
Toxicogenomic
Clinical toxicology
Chemical toxicology
Medical toxicology
Session 01. Pharmaceutical Sciences
The drug sciences are a
gathering of interdisciplinary spaces of study worried about the plan,
activity, conveyance, and attitude of medications. They apply information from
science (inorganic, physical, biochemical, and insightful), science (life
systems, physiology, natural chemistry, cell science, and sub-atomic science),
the study of disease transmission, measurements, chemometrics, math, physical
science, and synthetic designing.
The drug sciences are
additionally partitioned into a few explicit fortes, with four primary
branches:
• Pharmacology: The investigation of the biochemical and
physiological impacts of medications on individuals.
• Pharmacodynamics: The investigation of the cell and sub-atomic
connections of medications with their receptors. Just "How the medication
deals with the body"
• Pharmacokinetics: The investigation of the components that
control the grouping of medication at different destinations in the body.
Essentially "How the body deals with the medication"
• Pharmaceutical toxicology:
The investigation of the destructive or poisonous impacts of medications.
• Pharmacogenomics: The investigation of the legacy of trademark
examples of communication among medications and organic entities.
• Pharmaceutical
science: The investigation of
medication configuration to enhance pharmacokinetics and pharmacodynamics, and
amalgamation of new medication atoms (Medicinal Chemistry).
• Pharmaceutics: The examination and plan of medication
detailing for ideal conveyance, soundness, pharmacokinetics, and patient
acknowledgment.
• Pharmacognosy: The investigation of prescriptions got from
normal sources
Session 2: Drug
discovery
This research topic aims to publish data on recent advances
in early Drug Discovery
against emerging/neglected tropical diseases, including parasitic, bacterial,
viral, and fungal infections Here, we gather insightful data on the creation of
fresh experimental methods, the discovery of fresh therapeutic plans, and the
mode of action of traditional or cutting-edge antibacterial substances.
Over the past 40 years, the complexity of drug development
has multiplied, necessitating the preclinical stage of drug research, an
investigational new drug (IND) application, and extensive clinical testing
before FDA marketing clearance. Successful Drug Discovery is like finding a safe and
effective oasis in a chemical and biological desert. Because deserts are huge
and oases are tiny, analyses based on the drug development strategy reveal that
the discoverability of viable candidates is extremely sensitive to the accuracy
of predictions. Especially since Drug Discovery is very
difficult to measure late in the process before the project succeeds or fails.
Discovery Development
Preclinical research
Drug development process
Market monitoring
Session 3: Drug Development
Once a lead molecule
has been found through the process of drug discovery, the
process of drug development is used to bring a new pharmaceutical medicine to
market. Preclinical research on microbes and animals is part of this process,
as is requesting regulatory status, such as through the US Food and Drug
Administration, to begin human clinical trials for an investigational new
drug. It may also include the step of securing regulatory approval with a new
drug application to market the drug. It normally takes more than ten years for
a vaccine or medication to be approved, from concept to preclinical testing in
the lab to clinical trial development, including Phase I-III trials.
Session 4: FDA Drug
Review
The structural
similarities between the FDA's drug reviews and many other regulatory bodies'
judgments include high uncertainty, low reversibility, avoiding observable
error, and high political stakes that encourage lobbying by interested parties.
This essay investigates the policy implications of considering FDA drug evaluation as
a politically motivated information processing activity. I contend that the
incentives regulators face place restrictions on how quickly medication reviews
may be completed, that these motivations may make privatization efforts
difficult, and that political pressures may be helpful in identifying
high-priority pharmaceuticals.
·
Pharmaceuticals
·
Disease
·
Politics
·
HIV\ AIDS
·
Prescription Drug Costs
Session 5: Drug Discovery and Screening
The Drug Discovery Process
involves many different stages and series of actions. Typically, it can be
divided into four main stages: Early Drug Discovery, Pre-Clinical Phase,
Clinical Phases, and Regulatory Approval. Let's explore the major steps that
are taken in each of these stages to develop a new drug.
Drug discovery is a
process where a new drug or medication is discovered and aims to identify a
compound therapeutically useful in curing and treating disease. It includes a
wide range of scientific divisions, including biology, chemistry, and
pharmacology. This process associates with the identification of candidates,
synthesis, characterization, validation, optimization, screening, and assays
for therapeutic efficacy.
Drug screening is a process where potential drugs are
identified and optimized before the selection of a candidate drug to progress
to clinical trials. It can involve screening large volumes of chemicals for a
particular biological activity in high-throughput screening assays. Drug
screening mainly includes In-vivo and In-vivo models drug screening.
·
Discovery and Development.
·
Preclinical Researches
·
Clinical Researches
·
FDA Review.
·
FDA
Post-Market Safety Monitoring.
Session 6 : Clinical
trial in Drug Discovery
Today, people are
living longer because of the success of cancer treatments resulting from
previous clinical trials.
Through clinical trials and drug discovery, doctors determine whether new
treatments are safe, effective, and better than current treatments.
Participating in clinical
trials broadens our knowledge about cancer and helps improve cancer care
for future patients. In this way, clinical trials play a major role in the drug
development and Drug Design process.
Helps improve treatment. Clinical trials are key
to advancing the fight against cancer. In today's global scientific age,
clinical trials and drug Discovery are essential to bringing newer and better
medicines to market. Clinical
trials test potential treatments on human volunteers (subjects) to
determine whether they should be approved for wider use in the general
population. For the future of better healthcare, Clinical Trials are
important.
Prevention
trials
Treatment
trials
case-control
studies
Cross-sectional
studies
Session 7: FDA Post-Market Drug Safety Monitoring
Despite the fact that
data from clinical trials is crucial for understanding a drug's efficacy and safety,
it is difficult to know everything there is to know about a drug's safety at
the time of approval. There are restrictions despite the meticulous processes
in the drug development process.
As a result, throughout the weeks, months, and
sometimes even years that make up a product's existence on the market, the true
image of that product's safety actually changes. When FDA receives reports of
concerns with prescription and OTC medications, it may decide to add warnings
to the dosage or usage instructions or take other action in the case of more
serious problems.
In this session You
Will find information on:
·
Supplemental Application
·
INDs for Market Drugs
·
Manufacturer Inspections
·
Generic Drugs
·
Reporting Problems
Session 8: History Of Drug Discovery
Drug discovery and
development has a long history and dates back to the early days of human Civilization. The
first synthetic drug, chloral hydrate, was discovered in 1869 and introduced as
a sedative-hypnotic; it is still available today in some countries. Ancient people in what
is now Switzerland ate poppy seeds (the source of opium) in 2500 BCE. Coca
leaves (the source of cocaine) have been chewed for thousands of years. Folk
medicines made from plants and herbs have also been used since ancient times.
People in ancient Palestine drank wine in 350 BCE.
·
Chinese Medicine
·
Indian Medicine
·
Greek Medicine
·
Roman
Medicine
Session 9: Advanced
Drug Delivery System
An advanced drug delivery
system is also termed a Novel drug delivery system
which improves drug potency, controls drug release to give a sustained
therapeutic effect, and provides greater safety then finally it targets a drug
specifically to the desired tissue. Drug Delivery systems are developed to
deliver a required amount of drugs effectively to appropriate target sites and
to maintain the desired drug levels
Innovative Drug
Delivery Technologies
Implantable Drug
Delivery System
Pediatric Drug Delivery
systems
Routes of Drug
Administration
Session 10: Future trends impacting the pharmaceutical
industry
Gene and cell therapies
could make strong advancements in 2021 providing a new approach to treating
diseases. Cancer treatments have been advancing at an accelerated pace,
offering clinical benefits and increased specificity through engineered cell or
gene therapies. The
Indian pharma industry
is expected to grow to $130 billion by 2030 and become the leading provider of
medicines to the world, said Indian Pharmaceutical Alliance (IPA) Secretary
General, Sudarshan Jain on Thursday.
Top
Pharma Trends in 2022
·
Artificial Intelligence
·
Big Data & Analytics
·
Flexible Production.
·
Precision Medicine
·
Additive Manufacturing
·
Blockchain
·
Extended Reality (XR)
Session 11: Targeted
Drug Delivery
Targeted Drug Delivery,
at times called keen medication delivery, is a strategy for conveying a prescription to a patient in a way that expands the grouping of the drug in
certain pieces of the body compared with others. This method for conveyance
is to a great extent established on nanomedicine, which intends to utilize
nanoparticle-intervened drug conveyance to battle the destructions of ordinary
medication conveyance.
These nanoparticles would be stacked with
medications and focused on explicit pieces of the body where there is exclusively
sick tissue, in this manner staying away from collaboration with solid tissue.
The objective of a focus on drug conveyance framework is to drag out,
confine, target, and have secured drug cooperation with the ailing tissue.
The traditional medication
conveyance framework is the ingestion of the medication across a natural layer,
though the focus on the discharge framework delivers the medication in a dosing
structure. The benefits of the focused-on-discharge framework are a decrease
in the recurrence of the measurements taken by the patient, a more
uniform impact of the medication, a decrease in medication results, and
diminished variance in flowing medication levels. The impediment of the
framework is a significant expense, which makes efficiency more troublesome and
the diminished capacity to change the measurements.
Session 12: Pharmaceutical
Packaging
Pharmaceutical Packaging
is the bundles and the bundling measures for drug arrangements. It includes the
entirety of the activities from creation through drug appropriation channels to
the end shopper. Drug bundling is exceptionally directed yet with some variety
in the subtleties, contingent upon the nation of beginning or the locale.
A few normal variables can include:
confirmation of patient wellbeing, affirmation of the viability of the
medication through the expected time span of usability, consistency of the
medication through various creation parts, careful documentation, all things
considered, and measures, control of the conceivable movement of bundling segments
into the medication, control of corruption of the medication by oxygen,
dampness, heat, and so forth, avoidance of microbial defilement, sterility, and
so on Bundling is frequently associated with apportioning, dosing, and
utilization of the drug item. Correspondence of legitimate use and preventative
marks are additionally managed. Bundling is a basic piece of drug items.
Session 13. Pharmacovigilance And Drug Safety :
Pharmacovigilance is
also called drug safety, it is a pharmacological science that is related to
the detection, collection, assessment, monitoring, and prevention of adverse
effects with therapeutic products. The term "Pharmacovigilance" originated from Pharmakon (Greek for drug) and Vigilare (Latin for to stay
watch).
It usually focuses on adverse drug reactions,
or ADRs, that are defined as any response to a drug that is toxic and
undesirable, including lack of efficacy. Therapeutic errors like high doses,
misuse, and abuse of a drug as well as drug exposure during pregnancy and
breastfeeding, are significant.
Drug Safety
Advanced Methods in
Pharmacovigilance
Artificial Intelligence
in Pharmacovigilance
Ecopharmacovigilance
Substance-Based Medical
Devices.
Session 14.Pharmaceutical Industry:
The pharmaceutics 2023 industry
discovers, develops, produces, and markets drugs or pharmaceutical drugs for
use as medications to be administered to patients. , with the aim to cure them,
vaccinate them, or alleviating symptoms. Pharmaceutics 2023
companies may deal in generic or brand medications and medical devices.
They are subject to a
variety of laws and regulations that govern the patenting, testing, safety,
efficacy using drug testing, and marketing of drugs. The global pharmaceutics
2023 market produced treatments worth $1,228.45 billion in 2020 and showed a
compound annual growth rate (CAGR) of 1.8%.
Orphan Drugs
Drug Development and
Manufacturing
Drug Marketing
Industrial Safety and
Efficacy.
Session 15 :
Pharmacogenomics(Genomic Approaches to Drug Discovery)
The branch of genetics is concerned with how a person's genetic characteristics influence their likelihood
of responding to therapeutic medications. Pharmacogenomics is likely to lead to improved drug management for heart disease, cancer, asthma,
depression, and a variety of other diseases soon. It also intends to eliminate
the trial-and-error approach to prescription by pushing clinicians to learn
about their patient's genes, how they work, and how this may affect the efficacy
of their current or future medicines.
Drug therapy
Challenges of pharmacogenomics
Pharmacogenomics in clinical therapeutics
Cancer pharmacogenomics
Pharmacokinetic aspects
Clinical efficacy and
safety evaluation
Session 16: Current
Market and Technology
The high prevalence
rate of health diseases, the implementation of drug discovery, and
bioinformatics technology are the factors driving the drug discovery industry.
The technologies and
drug types are widely used for a variety of reasons. High Throughput Screening
(HTS) approaches enable the pharmaceutical industry
to screen vast libraries of drugs. Combinatorial chemistry is the process of
creating many structurally different molecules. Nanotechnology-based drug
discovery resolutions are beginning to produce significant new perspectives of
how biological systems work.
Global drug delivery
market
New technologies
Metabolomics
Biochips
Nanotechnology
Session 17:
Translational Medicine
Our patients and their diseases are the driving force behind translational medicine.
Translational research
spans the spectrum from molecular and cell biology through preclinical models
to patient investigations and back again, guided by this fundamental goal.
Encourages and promotes laboratory and clinical researchers to collaborate
across disciplines. Incorporates public wishes, with communities being involved
in determining their requirements for health innovation. Identifies and
promotes the use of the most effective medical and health practices.
Human diseases
Dissemination research
Diffusion research
New treatment and
approaches to medical care
Session 18:
Pharmaceutical Industry
The pharmaceutical industry is the discovery, development, and manufacture of drugs and medications
(pharmaceuticals) by public and private organizations. The pharmaceuticals industry
consists of drug manufacturers, biotechnology companies,
and the distribution and wholesale companies that handle the products produced.
Companies making related products, such as vitamins, other health supplements,
or diagnostic substances, are also included.
Research and development
Global sales and
marketing
Challenges that face the
pharmaceutical industry
Pharma companies
Session 19:
Transdermal drug delivery system
Transdermal therapy
systems are defined as self-contained, self-contained dosage forms that, when
applied to undamaged skin, release the drug to the systemic circulation at a
controlled rate. A simple patch that adheres to your skin like an adhesive
bandage and uses passive medication diffusion across the skin as the delivery
mechanism.
Skin-MediatedTherapies
and Vaccines
Risk-BasedStrategies
Cosmeceuticals
Latest advances in TDDS
Session 20: Toxicology
Toxicology is the scientific
study of the harmful effects of substances on living beings. It entails
observing and reporting symptoms that emerge because of toxic material
exposure. Toxicology
studies are used in the drug development process to assess the safety of possible
medication candidates. This is done with the help of relevant animal models and
tried-and-true methodologies. The goal is to translate the animal responses
into an understanding of the risk for human subjects
Toxicogenomic
Clinical toxicology
Chemical toxicology
Medical toxicology
Market Analysis
The global drug discovery market size was valued at US$ 74.96 billion in
2021 and is expected to be worth around US$ 161.76 billion by 2030,
growing at a CAGR of 8.9% from 2021 to 2030.

Growth Factor :
The global drug discovery market
is significantly driven by the rising prevalence of various chronic diseases,
rising healthcare expenditure, and patent expiration of certain popular drugs
across the globe. The global population is facing growing burden of various
diseases such as cardiovascular diseases, diabetes, cancer, respiratory
diseases, and neurological disorders, which is significantly fueling the demand
for the new and innovative drugs. The exponentially growing pharmaceutical
industry owing to the rapid growth of the biopharmaceuticals is expected to
drive the drug discovery market in the forthcoming years. The biopharmaceutical
industry is growing at a rapid pace owing to the rising investments by the
government and corporate for the development of new medicines to treat chronic
diseases. Moreover, the favorable government regulations coupled with the
active role of the authorities such as FDA and EMA is fueling the market growth.
The changing lifestyle, shifting
consumption pattern, unhealthy food habits, rising pollution levels, and
physical inactivity is resulting in the growing burden of various diseases like
cancer, diabetes, and cardiovascular diseases. According to the International
Agency for Research on Cancer, around 19.3 million new cancer cases and around
10 million cancer deaths were reported in 2020. As per the International
Diabetes Federation, around 783 million people across the globe are estimated
to live with diabetes by 2045. Further, over 1.2 million children and teenagers
are suffering from type 1 diabetes. According to the World Health Organization,
the cardiovascular diseases results in almost 18 million deaths each year and
it is the leading cause of death across the globe. Thus, the demand for the
innovative drugs that can cure chronic diseases is high among the global
population, which in turn fuels the growth of the drug discovery market. The
rising investments by the pharmaceutical companies in the research &
development of various new drugs and clinical trials research is expected to
propel the growth of the global
drug discovery market.
Some of the prominent players in the
global drug discovery market include:
- Pfizer
Inc.
- GlaxoSmithKline
PLC
- Merck
& Co. Inc.
- Agilent
Technologies Inc.
- Eli
Lilly and Company
- F.
Hoffmann-La Roche Ltd
- Bayer
AG
- Abbott
Laboratories Inc.
- AstraZeneca
PLC
- Shimadzu
Corp.
Drug Discovery Market, By Drug Type
- Small
Molecule Drugs
- Biologic
Drugs
Based on Drug Type, The market is segmented into
Small-Molecule Drugs and Biologic Drugs. Small Molecule Drugs
are predicted to account for the biggest market share during the forecasted
period since they are simple, well-defined, and straightforward to characterize.
Because of these characteristics, they can penetrate cells fast, alter
molecules, and cause cancer cells to die. Small molecules continue to play an
important role in the development of new medicines in four core therapeutic
areas: oncology, cardiovascular illness, autoimmune disease, and respiratory
diseases. The potential of small molecules in the pharmaceutical portfolio is
enhanced by their increased relevance and highly effective components. All of
these reasons are expected to drive segment expansion.
Drug Discovery Market, By Technology
- High
Throughput Screening
- Pharmacogenomics
- Nanotechnology
Based on Technology, the market is segmented into
High Throughput Screening, Pharmacogenomics, and Nanotechnology. Technology is
important in all aspects of small molecule Drug Discovery, from
target selection and validation to lead optimization. As a result, technical
improvements have been a driving force in the sector. The ongoing focus
resulted in an increase in the number of targets identified, validated, and
drugs developed.
Growth Factor :
The global drug discovery market
is significantly driven by the rising prevalence of various chronic diseases,
rising healthcare expenditure, and patent expiration of certain popular drugs
across the globe. The global population is facing growing burden of various
diseases such as cardiovascular diseases, diabetes, cancer, respiratory
diseases, and neurological disorders, which is significantly fueling the demand
for the new and innovative drugs. The exponentially growing pharmaceutical
industry owing to the rapid growth of the biopharmaceuticals is expected to
drive the drug discovery market in the forthcoming years. The biopharmaceutical
industry is growing at a rapid pace owing to the rising investments by the
government and corporate for the development of new medicines to treat chronic
diseases. Moreover, the favorable government regulations coupled with the
active role of the authorities such as FDA and EMA is fueling the market growth.
The changing lifestyle, shifting
consumption pattern, unhealthy food habits, rising pollution levels, and
physical inactivity is resulting in the growing burden of various diseases like
cancer, diabetes, and cardiovascular diseases. According to the International
Agency for Research on Cancer, around 19.3 million new cancer cases and around
10 million cancer deaths were reported in 2020. As per the International
Diabetes Federation, around 783 million people across the globe are estimated
to live with diabetes by 2045. Further, over 1.2 million children and teenagers
are suffering from type 1 diabetes. According to the World Health Organization,
the cardiovascular diseases results in almost 18 million deaths each year and
it is the leading cause of death across the globe. Thus, the demand for the
innovative drugs that can cure chronic diseases is high among the global
population, which in turn fuels the growth of the drug discovery market. The
rising investments by the pharmaceutical companies in the research &
development of various new drugs and clinical trials research is expected to
propel the growth of the global
drug discovery market.
Some of the prominent players in the
global drug discovery market include:
Drug Discovery Market, By Drug Type
Based on Drug Type, The market is segmented into
Small-Molecule Drugs and Biologic Drugs. Small Molecule Drugs
are predicted to account for the biggest market share during the forecasted
period since they are simple, well-defined, and straightforward to characterize.
Because of these characteristics, they can penetrate cells fast, alter
molecules, and cause cancer cells to die. Small molecules continue to play an
important role in the development of new medicines in four core therapeutic
areas: oncology, cardiovascular illness, autoimmune disease, and respiratory
diseases. The potential of small molecules in the pharmaceutical portfolio is
enhanced by their increased relevance and highly effective components. All of
these reasons are expected to drive segment expansion.
Drug Discovery Market, By Technology
Based on Technology, the market is segmented into
High Throughput Screening, Pharmacogenomics, and Nanotechnology. Technology is
important in all aspects of small molecule Drug Discovery, from
target selection and validation to lead optimization. As a result, technical
improvements have been a driving force in the sector. The ongoing focus
resulted in an increase in the number of targets identified, validated, and
drugs developed.
Report
Scope
REPORT ATTRIBUTES |
DETAILS |
STUDY PERIOD |
2018-2030 |
BASE YEAR |
2021 |
FORECAST YEAR |
2023-2030 |
HISTORICAL PERIOD |
2018-2020 |
UNIT |
Value (USD Billion) |
KEY COMPANIES PROFILED |
Pfizer Inc., GlaxoSmithKline PLC, Merck & Co.
Inc., Agilent Technologies Inc., Eli Lilly and Company, F. Hoffmann-La Roche
Ltd, Bayer AG. |
SEGMENTS COVERED |
By Drug Type, By Technology, By End-Users, And By
Geography. |
CUSTOMIZATION SCOPE |
Free report customization (equivalent up to 4
analyst’s working days) with purchase. Addition or alteration to country,
regional & segment scope |
Scope of the Report
According to the
scope of the report,
Drug Research is the process aimed at identifying therapeutically useful compounds for the
treatment and cure of disease. Drug discovery usually
begins with molecules that either address biological targets that have been
shown to be involved in disease development
or have interesting biological activities. In recent times, drug discovery has
advanced significantly with new technologies that have made the process more sophisticated, more precise, and less
time consuming. The drug discovery market is divided by drug type (small
molecule drugs and biologics), technology (high-throughput screening,
pharmacogenomics, combinatorial chemistry, nanotechnology, and other
technologies), and end users (pharmaceutical companies, contract research
organizations (CROs)). ) etc.). end users), Geography (North America, Europe,
Asia Pacific, Middle East, Africa, South America). The market report also
includes estimated market size and trends for 17 countries in key regions of
the world. This report provides the value (Million USD) for the above segment.